Mohanlal admitted at Amritha Institute of Medical science


Mohanlal, the pulse of Malayalam film industry is now admitted to hospital it has been four days. He has been suffering from sever back pain for few days but has been postponing treatment because of his busy schedule.



Superstar Mohanlal, the pulse of Malayalam film industry is now admitted to hospital it has been four days. He has been suffering from sever back pain for few days but has been postponing treatment because of his busy schedule. He is admitted in Amritha Instiute of Medical Sciences (AIMS), Ernakulam. The actor has been suffering from spondilytis for quite some time now and has been undergoing treatment for the same. Mohanlal is now awaiting the release of his latest film "Peruchazhi", which is to release on 29th August.

Presently the actor is undergoing special treatment at Amritha Institute of Medical Science, Ernakulam which has a dedicated team of doctors, physicians, nurses and other healthcare professionals. It has an outstanding reputation of being one of the best hospitals in Kerala. This hospital has a state of the art facilities. This institution was found on the guiding principles of compassionate services to the people, charity and excellence through perfection. All mohanlal fans across the state are eager to know the condition of their beloved actor and praying for his betterment.

Mohanlal was suffering from this for a while and this is considered to be a type of arthritis. It is an inflammation of vertibre and a type of spondylopathy. In many cases it involves one or more vertebral joints. Major symptoms of spondilytis include pain and stifness from neck down and back pain, it leads to constant stiffness and pain in lower back, buttocks and hips that continue for a prolonged period of time. People suffering from such problem face day to day activities challenging, they cannot continue to sit or stand in a particular position for more time. Spondilitis is common in people over the age of 45, men are more prone to this than women's.